ARTICLE | Company News
Almac, Shin Poong deal
May 6, 2013 7:00 AM UTC
Almac's Almac Discovery Ltd. unit granted Shin Poong rights to develop and market ALM201 in South Korea. The tubulin disrupting agent with anti-angiogenic properties has completed preclinical testin...